Literature DB >> 12941209

Management of Pulmonary Atresia with Ventricular Septal Defect.

Douglas D. Mair1, Franciso J. Puga.   

Abstract

It has been nearly 40 years since Kirklin, at the Mayo Clinic in 1964, performed the first surgical repair of pulmonary atresia with ventricular septal defect using a nonvalved extracardiac conduit, which he created out of the patient's pericardium, and this patient continues to do well. In the subsequent four decades, great advances have been made in the diagnosis, with regard to the often very complex anatomy of pulmonary blood supply that this extremely heterogeneous group of patients manifest, and their subsequent surgical management. Unifocalization procedures have permitted eventual complete correction in patients with nonconfluent pulmonary artery segments, and advances in infant surgery have enabled most patients to achieve correction in the early childhood years. Although the ideal extracardiac conduit has yet to be developed, necessitating periodic conduit replacement in corrected patients, the late results in this group of patients are generally excellent, with many now achieving survival well into the adulthood years with good quality of life. Continued advances in surgery and interventional catheterization techniques hold great promise for ever-improving outcomes in children being born with this complex congenital cardiovascular malformation.

Entities:  

Year:  2003        PMID: 12941209     DOI: 10.1007/s11936-003-0047-3

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  25 in total

1.  A genetic etiology for DiGeorge syndrome: consistent deletions and microdeletions of 22q11.

Authors:  D A Driscoll; M L Budarf; B S Emanuel
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

2.  One-stage complete unifocalization in infants: when should the ventricular septal defect be closed?

Authors:  V M Reddy; E Petrossian; D B McElhinney; P Moore; D F Teitel; F L Hanley
Journal:  J Thorac Cardiovasc Surg       Date:  1997-05       Impact factor: 5.209

3.  Intravascular stents in congenital heart disease: short- and long-term results from a large single-center experience.

Authors:  K M Shaffer; C E Mullins; R G Grifka; M P O'Laughlin; W McMahon; F F Ing; M R Nihill
Journal:  J Am Coll Cardiol       Date:  1998-03-01       Impact factor: 24.094

4.  Early and intermediate outcomes after repair of pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries: experience with 85 patients.

Authors:  V M Reddy; D B McElhinney; Z Amin; P Moore; A J Parry; D F Teitel; F L Hanley
Journal:  Circulation       Date:  2000-04-18       Impact factor: 29.690

5.  Pulmonary blood supply in patients with pulmonary atresia and ventricular septal defect.

Authors:  P K Liao; W D Edwards; P R Julsrud; F J Puga; G K Danielson; R H Feldt
Journal:  J Am Coll Cardiol       Date:  1985-12       Impact factor: 24.094

6.  Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counselling and prenatal diagnosis.

Authors:  D A Driscoll; J Salvin; B Sellinger; M L Budarf; D M McDonald-McGinn; E H Zackai; B S Emanuel
Journal:  J Med Genet       Date:  1993-10       Impact factor: 6.318

7.  Very small pulmonary arteries: central end-to-side shunt.

Authors:  K G Watterson; J L Wilkinson; T R Karl; R B Mee
Journal:  Ann Thorac Surg       Date:  1991-11       Impact factor: 4.330

8.  Total repair of pulmonary atresia with ventricular septal defect and major aortopulmonary collaterals: an integrated approach.

Authors:  A Carotti; R M Di Donato; C Squitieri; P Guccione; G Catena
Journal:  J Thorac Cardiovasc Surg       Date:  1998-12       Impact factor: 5.209

9.  Midline one-stage complete unifocalization and repair of pulmonary atresia with ventricular septal defect and major aortopulmonary collaterals.

Authors:  V M Reddy; J R Liddicoat; F L Hanley
Journal:  J Thorac Cardiovasc Surg       Date:  1995-05       Impact factor: 5.209

10.  Cardiovascular anomalies in DiGeorge syndrome and importance of neural crest as a possible pathogenetic factor.

Authors:  L H Van Mierop; L M Kutsche
Journal:  Am J Cardiol       Date:  1986-07-01       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.